Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Cardiol Therapeutics Inc T.CRDL

Alternate Symbol(s):  CRDL

Cardiol Therapeutics Inc. is a clinical-stage life sciences company. The Company is focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. Its lead drug candidate, CardiolRx (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the treatment of heart disease. It is recognized that cannabidiol inhibits activation of the inflammasome pathway, an intracellular process known to play an important role in the development and progression of inflammation and fibrosis associated with myocarditis, pericarditis, and heart failure. It is also developing CRD-38, a novel subcutaneously administered drug intended for use in heart failure. It has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart.


TSX:CRDL - Post by User

Comment by NewFanCBDon Oct 19, 2020 11:05am
148 Views
Post# 31738772

RE:Pricing Cortalex

RE:Pricing CortalexI don't think these numbers are correct in my opinion. From my DD, the price per gram of plant based CBD is more like $95.00 Cdn, and Cortalex is more like around $125.00 - $130.00 because it is a premium product - based on a phone conversation I had with the company's IR person in the summer. So like, here are a couple of products off the shoppers drug mart site that I found that supports my thoughts. https://cannabis.shoppersdrugmart.ca/en_CA/products/Aqualitas-Aqualitas-AQ-High-CBD-Oil-Hybrid/317 https://cannabis.shoppersdrugmart.ca/en_CA/products/TGOD-TGOD-Care-Organic-CBD-Oil-Sativa/302 I also believe that the Cortalex product has less than 10ppm THC from batch to batch at Dalton Pharma. This should bring a lot of peace of mind to the end consumer because this product is pharmaceutically produced in a 'cGMP facility'. This makes this a very cool situation for Cardiol and, as far as I can tell, it makes Cortalex the ONLY product on the market that can replicate these types of high standards. Just my 2 cents here. I've tried to find another product like this that is produced like this - I cant find it. Hope that helps.
<< Previous
Bullboard Posts
Next >>